Anitha Krishnan
Company: Aviceda Therapeutics
Job title: Executive Director
Seminars:
PolySia Nanoparticle Modulates Macrophages Response Through Siglec Agonism as Mechanism of Action for Macular Degeneration Treatment 1:30 pm
Revolutionizing the latest advancement in genomics and proteomics to improve understanding of disease pathogenesis, beyond simple genetic mutations Uncovering the relationships between genomic alterations and disease phenotypes, and gaining insights into how inflammation can lead to different disease manifestations Discussing emerging methodologies and technologies advancing the understanding of complex molecular interactions underlying disease progression and…Read more
day: Conference Day 1
Chair’s Opening Remarks 8:25 am
day: Conference Day Two